Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A Knight-Swift Transportat Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Akero Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Repay Holdings Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A BANNER CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A US Foods Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A HERITAGE COMMERCE CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A QIAGEN N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Edwards Lifesciences Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A STEVEN MADDEN, LTD. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Ameresco, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G LendingClub Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Denali Therapeutics Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GULFPORT ENERGY CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GLOBE LIFE INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G POOL CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G REGIONS FINANCIAL CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G MNTN, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Perella Weinberg Partner Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G WEYERHAEUSER CO Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Jamf Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A RUSH ENTERPRISES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Immatics N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Targa Resources Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GIBRALTAR INDUSTRIES, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Excelerate Energy, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Voya Financial, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A HOPE BANCORP INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G AtriCure, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Sprout Social, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
BBOT begins trading on Nasdaq after $382M SPAC merger completion
-
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
-
ICG plc: Notification of Major Holdings
-
HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
-
Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics
-
Form SCHEDULE 13G/A MVB FINANCIAL CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Immunocore Holdings plc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Investar Holding Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Immunocore Holdings plc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
MIAX-parent Miami International targets $1.7 billion valuation in rare exchange IPO
-
FalconX Expands into Latin America to Support the Region's Largest Financial Institutions
-
Wellington-led funding boosts Vanta's valuation by 69% in a year
-
Vanta Raises $150M Series D to Power the Future of AI-Driven Trust

